Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.
Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.
复制标题
DOI：
10.1093/clinids/8.2.228
复制
发表时间：
1986-03
期刊：
影响因子：
--
通讯作者：
J. Walsh
中科院分区：
文献类型：
--
作者：
J. Walsh
用于诊断阿米巴病的各种不完善的测试的主要问题严重限制了对其严重性和流行病学的理解。更大的障碍是现有方法在世界不同地区的应用多种多样、不一致。最准确的估计表明，1981 年大约有 4.8 亿人感染了溶组织阿米巴，3600 万人患上了致残性结肠炎或肠外脓肿。至少有 4 万人死于阿米巴病，在全球范围内，阿米巴病可能在寄生虫死亡原因中排名第三，仅次于疟疾和血吸虫病。随着需要改进的诊断工具的开发，其发生频率和流行病学仍有许多待了解。
Major problems with a wide array of imperfect tests for diagnosis of amebiasis severely limit the understanding of its magnitude and epidemiology. A greater hindrance is the varied, inconsistent application of existing methods in different areas of the world. The best estimates suggest that probably 480 million people were infected with Entamoeba histolytica and 36 million developed disabling colitis or extraintestinal abscesses in 1981. At least 40 thousand deaths are attributable to amebiasis, and on a global scale, amebiasis likely ranks third among parasitic causes of death, behind only malaria and schistosomiasis. Much remains to be learned of its frequency of occurrence and epidemiology as needed improved diagnostic tools are developed.